Overall Survival of 125 poor-risk FL according to

Prolonged Survival Of Poor Risk Follicular Lymphoma
Patients Following Primary Treatment With RituximabSupplemented CHOP Or HDS With Autograft: Long-Term
Results Of The Multicenter Randomized GITMO/FIL Trial
by Corrado Tarella, Fabio Benedetti, Carola Boccomini, Caterina Patti, Anna Maria
Barbui, Alessandro Pulsoni, Maurizio Musso, Anna Marina Liberati, Guido Gini,
Claudia Castellino, Fausto Rossini, Fabio Ciceri, Delia Rota Scalabrini, Caterina
Stelitano, Francesco Di Raimondo, Tommasina Perrone, Alessandra Tucci, Atto
Billio, Francesco Zallio, Valerio Zoli, Angela Congiu, Franco Narni, Alessandra Dondi,
Guido Parvis, Gianpietro Semenzato, Paolo Corradini, Riccardo Bruna, Angela Gueli,
Barbara Mantoan, Roberto Passera, Michele Magni, and Marco Ladetto
Blood
Volume 122(21):551-551
November 15, 2013
©2013 by American Society of Hematology
Overall Survival of 125 poor-risk FL according to treatment arm.
Fabio Benedetti et al. Blood 2013;122:551
©2013 by American Society of Hematology
Overall Survival according to (A) CR or (B) MR achievement.
Fabio Benedetti et al. Blood 2013;122:551
©2013 by American Society of Hematology